Exploring risk factors for poor outcomes in pneumonia patients
Official title: Surviving Pneumonia
Run by Nordsjaellands Hospital · NCT03795662 · Data updated 2026-11-12
This study looks at what factors might lead to worse recovery in adults with pneumonia to help improve their treatment and outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 2500 (estimated) |
| Sponsor | Nordsjaellands Hospital Academic / other |
| Locations | 1 site (Hillerød) |
| Status | Recruiting |
| Started | January 7, 2019 |
| Main results expected | December 31, 2023 |
| Study ends | December 31, 2038 |
| Registry record updated | April 29, 2021 |
| Trial ID | NCT03795662 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 and older who have been admitted with community-acquired pneumonia and meet specific clinical criteria.
✕Probably not a fit
Patients who are unable or unwilling to provide informed consent will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study investigates the risk factors associated with poor prognosis in patients diagnosed with community-acquired pneumonia (CAP) at North Zealand Hospital. Over a five-year period, patients aged 18 and older will be invited to participate, providing data through questionnaires, anthropometric measures, laboratory tests, and biomaterials collected at various stages of their hospital stay. The study aims to track clinical outcomes, including mortality and the development of diabetes, to better understand the factors influencing recovery from CAP.
Why it matters
Potential benefit: If successful, this study could lead to improved management strategies for patients with community-acquired pneumonia, potentially reducing mortality and complications.
How similar studies have gone: While similar studies have explored pneumonia outcomes, this specific observational approach focusing on multiple risk factors is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Infiltrate on chest radiograph plus one or more of the following: * Fever (temperature, ≥38.0°C) * Hypothermia (\<35.0°C), * New cough with or without sputum production * Pleuritic chest pain * Dyspnea * Altered breath sounds on auscultation. Exclusion Criteria: * Patients unable to give informed consent * Patients unwilling to give informed consent
Where it's running
-
Department of Pulmonary and Infectious Diseases, Nordsjællands Hospital
Hillerød, Denmark Recruiting
Study contacts
- Principal investigator: Birgitte Lindegaard, Assoc. Prof — Nordsjaellands Hospital
- Study coordinator: Camilla Ryrsø, MSc
- Email: camilla.koch.ryrsoe.01@regionh.dk
- Phone: +4548293250
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
How frailty affects outcomes in older people with pneumonia in the ER
This study will test whether a quick bedside frailty score (the Clinical Frailty Scale) can help predict short-term death and serious complications in people aged 65 and older who come to the emergency department with pneumonia.
-
Fever clinic tracking of acute respiratory infections
This project follows adults who come to a fever clinic with respiratory infections to see how their symptoms, test results, and outcomes change over time.
-
Azithromycin versus doxycycline as atypical coverage for adults hospitalized with community-acquired pneumonia on a beta-lactam
This trial will test whether adding azithromycin or doxycycline to a beta-lactam works better and is safer for adults hospitalized with community-acquired pneumonia.
-
Noninvasive breathing support for severe community-acquired pneumonia
This trial tests whether high-velocity nasal insufflation (HVNI) or standard noninvasive ventilation (NIV) better helps adults with community-acquired pneumonia and low oxygen levels avoid intubation or death within 48 hours.
-
Antibiotic strategies for young children with pneumonia in outpatient care
This trial will see if a 'watch-and-wait' Safety Net Antibiotic Prescribing (SNAP) approach can safely reduce antibiotic use compared with immediate antibiotics in children aged 12 months to under 6 years with mild community-acquired pneumonia.
-
Awake prone positioning for adults with community-acquired pneumonia on high-flow nasal oxygen.
This trial will test whether asking adults with community-acquired pneumonia who are on high-flow nasal oxygen to lie on their stomach while awake can reduce the need for a breathing tube.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.